Evaluation of Lipid Profile and Some Renal Parameters in Some Selected Ethnic Population with Fat-mass and Obesity-associated Gene (FTO) Variants in Niger Delta, Nigeria
Cardiology and Angiology: An International Journal,
Aim: To evaluate lipid profile and some renal parameters in some selected ethnic population with fat-mass and obesity-associated gene (FTO) variants in Niger Delta, Nigeria.
Study Design: Case-controlled observational study.
Place and Duration of Study: Federal Medical Centre, Asaba, Delta State and Safety Molecular Pathology Laboratory, Enugu, Nigeria, between March 2020 and February 2022.
Methodology: Changes in lipid profile and some renal parameters in FTO gene was studied in ninety-eight (98) type 2 diabetes (T2D) subjects (78 cases and 20 controls) from four different tribes in the Niger Delta region, Nigeria. Multistage sampling method was employed in the subject selection. The subjects were first separated into two groups – new cases (less than a year of diagnosis as Diabetic) and old cases (one year & above). Equal number of samples was then randomly collected from each of the cluster groups. 10mls of blood was collected into plain bottles for the assay of the above-named markers, and were assayed using spectrophotometric and ELISA methods. The data were analyzed using GraphPad Prism, version 8.0.2 and p values less than .05 were considered statistically significant.
Results: The results showed that the Ijaw tribe had the highest mean total cholesterol (TCHOL), low density lipoproteins (LDL), Castelli Risk Ratio (CRR), atherogenic coefficient (AC) values (5.36 ± 0.99, 3.36 ± 0.87 mmol/l,3.76 ± 1.18 and 2.86 ± 1.16) respectively, which were significantly higher (P<.05) than those of the control group, while the Urhobo tribe had the highest mean TG and AIP values (1.47 ± 0.51 mmo/l and 0.08 ± 0.01), The control subjects had the highest mean HDL values (1.51 ± 0.49mmo/l), which were significantly higher(P<.05) than that of the control subjects. Mean creatinine level was highest in the control group (101.1 ± 21.24 µmol/L), while the Urhobo tribe had the highest mean MDRD levels (94.15 ±36.17 ml/min). Special diets did not contribute to any significant difference in the biochemical indices of the subjects apart from significant changes in the levels of triglyceride.
Conclusion: From the results, we conclude that the levels of lipid profile varied with the tribe for subjects with FTO variants and control subjects and only triglyceride levels are affected by specific diets.
- Lipid profile
- renal parameters
- FTO variants
- Niger Delta
How to Cite
Zhang X, Qi Q, Zhang C, Smith SR, Hu FB, Sacks FM, Bray GA, Qi L. FTO genotype and 2-year change in body composition and fat distribution in response to weight-loss diets: the POUNDS LOST Trial. Diabetes, 2012;61(11):3005-11.
Abdullah A, Peeters A, de Courten M, Stoelwinder J. The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies. Diabetes Research and Clinical Practice. 2010;89(3):309-19.
Liu G, Zhu H, Lagou V, Gutin B, Stallmann-Jorgensen IS, Treiber FA, Dong Y, Snieder H. FTO variant rs9939609 is associated with body mass index and waist circumference, but not with energy intake or physical activity in European and African-American youth. Medical Genetics , 2010;11:57-67.
Peng S, Zhu Y, Xu F, Ren X, Li X, Lai M. FTO gene polymorphisms and obesity risk: a meta-analysis. Biomed Central Medicine. 2011;9:71-86
Meyre D, Delplanque J, Chevre JC, Lecoeur C, Lobbens S, Gallina S. Genome-wide association study for early-onset and morbid adult obesity identifies three new risk loci in European populations. Nature Genetics, 2009; 41(2): 157-9.
Locke AE, Kahali B, Berndt SI, Justice AE, Pers TH, Day FR. Genetic studies of body mass index yield new insights for obesity biology. Nature, 2015; 518(7538): 197-206.
Frayling TM, Timpson NJ, Weedon MN, Zeggini E, Freathy RM, Lindgren CM. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science, 2007; 316(5826): 889-94.
Dotevall A, Johansson S, Wilhelmsen L, Rosengren A. Increased levels of triglycerides, BMI and blood pressure and low physical activity increase the risk of diabetes in Swedish women. A prospective 18-year follow-up of the BEDA study. Diabetic Medicine, 2004;21(6):615–22.
Olamoyegun MA, Oluyombo R, Asaolu SO. Evaluation of dyslipidemia, lipid ratios, and atherogenic index as cardiovascular risk factors among semi-urban dwellers in Nigeria. Annals of African Medicine. 2016;15(4):194-9.
Rached FH, Chapman MJ, Kontush A. An overview of the new frontiers in the treatment of atherogenic dyslipidemias. Clinical Pharmacology & Therapeutics. 2014;96:57-63.
Okafor CI. The metabolic syndrome in Africa: Current trends. Indian Journal of Endocrinology and Metabolism. 2012;16: 56-66.
Pencina MJ, Navar-Boggan AM, D'Agostino RB. Sr., Williams K, Neely B, Sniderman AD. Application of new cholesterol guidelines to a population-based sample. New England Journal of Medicine, 2014;370:1422-31.
Superko HR, King S. 3rd. Lipid management to reduce cardiovascular risk: A new strategy is required. Circulation, 2008;117:560-8.
Bafna A, Maheshwari RS, Ved RK, Sarkar PD, Batham AR. Study of Atherogenic Indices in Nephrotic Syndrome. International Journal of Biological and Medical Research, 2012;3(3): 2257-60.
Nwagha UI, Ikekpeazu EJ, Ejezie FE, Neboh EE, Maduka IC. Atherogenic index of plasma as useful predictor of cardiovascular risk among postmenopausal women in Enugu. Nigeria. African Health Sciences. 2010;10(3):248–52.
Dobiásová M, Urbanová Z, Samánek M. Relations between particle size of HDL and LDL lipoproteins and cholesterol esterification rate. Physiological Research. 2005;54(2):159–65.
Hartopo AB, Arso IA, Setianto BY. Low plasma atherogenic index associated with poor prognosis in hospitalized patients with acute myocardial infarction. Acta Medica Indonesiana, 2016;48(2):106–13.
Deric M, Kojic-Damjanov S, Cabarkapa V, Eremic N. Biochemical Markers of Atherosclerosis. Journal of Microbiology and Biotechnology. 2008;27(2):148-53.
Longo DL, Kasper DL, Jameson JL, Fauci, AS, Hauser SL, Loscalzo J. The pathogenesis, prevention and treatment of atherosclerosis. In Harrison’s (eds), Principles of Internal Medicine (17th edition, pp1501-1509). New York: McGraw-Hill, 2008.
Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, Kusek JW, Van Lent F. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Annals of Internal Medicine. 2006;145(4):247-54.
Nnaemeka AN. Environmental pollution and associated health hazards to host communities (Case study: Niger delta region of Nigeria). Central Asian Journal of Environmental Science and Technology Innovation, 2020;1(1): 30-42.
Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clinical Chemistry. 1974;20(4):470-5.
McGowan MW, Artiss JD, Strandbergh DR, Zak B. A Peroxidase-Coupled method for the Colorimetric determination of serum triglyceride. Clinical Chemistry, 1983; 9(3):538-42.
Warnick GR, Mayfield C, Benderson J, Chen JS, Alberts JJ. HDL cholesterol quantitation by phosphotungstate-Mg2+ and by dextran sulfate-Mn2+-polyethylene glycol precipitation, both with enzymatic cholesterol assay compared with the lipid research method. American Journal of Clinical Pathology, 1982; 78(5): 718-23.
Assman G, Jabs HU, Kohnert U, Nolte W, Schriewer H. LDL-cholesterol determination in blood serum following precipitation of LDL with polyvinylsulfate. Clinica Chimica Acta. 1984;140:77-83.
Bartels H, Bohmer M. Quantitative Determination of Creatinine. Clinica Chimica Acta. 1972;37: 193-7.
Scicali R, Di Pino A, Ferrara V, Urbano F, Piro S, Rabuazzo AM, Purrello F. New treatment options for lipid-lowering therapy in subjects with type 2 diabetes. Acta Diabetologica. 2018;55:209–18.
Filippatos TD, Rizos EC, Tsimihodimos V, Gazi IF, Tselepis AD, Elisaf MS. Small high-density lipoprotein (HDL) subclasses are increased with decreased activity of HDL-associated phospholipase A2 in subjects with prediabetes. Lipids, 2013; 48(6): 547–55.
Li, Z, Huang Q, Sun L, Bao T, Dai Z. Atherogenic Index in Type 2 Diabetes and Its Relationship with Chronic Microvascular Complications. International Journal of Endocrinology, 2018;2018: 1-9.
Mudhaffar SK. Atherogenic index of plasma (AIP) as a parameter in predicting cardiovascular risk in males compared to the conventional dyslipidemic indices (cholesterol ratios), Karbala. Journal of Medicine. 2013;6(1):506–13.
Abstract View: 29 times
PDF Download: 15 times